AEye (LIDR) Q2 2026 earnings summary

Executive summary

• Q2 2026 revenue surged nine-fold year-over-year and doubled sequentially, with first-half revenue of $303K already exceeding full-year 2025 levels, driven by higher Apollo lidar sales and contract development revenue.

• Commercial pipeline reached a record with 25 revenue-generating customers, up 19% from Q1, and expanded into new verticals such as sports analytics through a deal with Alive3D.

• Defense became the most active vertical, with engagements doubling quarter-over-quarter, repeat orders, and international expansion via SynTech.

• Apollo validated on NVIDIA DRIVE AGX Thor, enhancing automotive ecosystem partnerships and integration with next-gen AI platforms.

• Software-defined architecture and new partnerships enable rapid adaptation to new use cases and expansion into additional markets.

Financial highlights

• Q2 2026 revenue was $202K, up from $101K in Q1 and $22K in Q2 2025; first-half 2026 revenue reached $303K, surpassing 2025's $233K.

• GAAP net loss for Q2 2026 was $(10.0)M ($0.22/share); non-GAAP net loss was $(7.6)M ($0.17/share); net loss for the first half was $18.4M.

• Operating expenses for Q2 2026 were $10.6M, with more than half due to non-cash stock-based compensation.

• Cash, cash equivalents, and marketable securities totaled $71.5M as of June 30, 2026.

• Cash consumption in Q2 2026 was $7.5M; net cash used in operating activities for the first half was $15.8M.

Outlook and guidance

• Full-year 2026 cash consumption expected to be $30–$35M, including ~$5M in working capital.

• Cash balance projected to provide operational runway well into 2028, supporting commercialization and customer deployments.

• Focus remains on converting pipeline engagements into deployments and sustaining quarter-on-quarter revenue growth.

• Near-term revenue growth expected from Non-Automotive markets, with Automotive growth dependent on OEM program wins.

• Management expects continued operating losses as commercialization efforts ramp up.